MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, K.
Right arrow Articles by Kufe, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, K.
Right arrow Articles by Kufe, D.

Vol. 60, Issue 6, 1431-1438, December 2001

Negative Regulation of the SHPTP1 Protein Tyrosine Phosphatase by Protein Kinase C delta  in Response to DNA Damage

Kiyotsugu Yoshida and Donald Kufe

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

The SHPTP1 protein tyrosine phosphatase is activated by the c-Abl and Lyn tyrosine kinases in the cellular response to genotoxic stress. However, signaling mechanisms involved in the negative regulation of SHPTP1 are unknown. This study demonstrates that protein kinase C delta  (PKCdelta ) associates with SHPTP1. The PKCdelta catalytic domain binds directly to SHPTP1. The results also demonstrate that PKCdelta is required, at least in part, for phosphorylation and inactivation of SHPTP1. The phosphatase activity of SHPTP1 was attenuated by coincubation with PKCdelta in vitro. In addition, treatment of U-937 human myeloid leukemia cells with 1-beta -D-arabinofuranosylcytosine (ara-C) was associated with induction of the PKCdelta kinase function and inhibition of SHPTP1 activity. Down-regulation of SHPTP1 by ara-C was blocked by the PKCdelta inhibitor rottlerin but not by the PKCalpha and -beta inhibitor Gö6976. Moreover, transient coexpression studies with a dominant-negative mutant of PKCdelta demonstrate that the kinase activity of PKCdelta is required for the down-regulation of SHPTP1. These findings support the functional interaction between PKCdelta and SHPTP1 in the cellular response to DNA damage.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
J. Kimura, S. T. Nguyen, H. Liu, N. Taira, Y. Miki, and K. Yoshida
A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress
Nucleic Acids Res., September 1, 2008; 36(16): 5250 - 5259.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H. Liu, Z.-G. Lu, Y. Miki, and K. Yoshida
Protein Kinase C {delta} Induces Transcription of the TP53 Tumor Suppressor Gene by Controlling Death-Promoting Factor Btf in the Apoptotic Response to DNA Damage
Mol. Cell. Biol., December 15, 2007; 27(24): 8480 - 8491.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. A. Alvarez-Arias and K. S. Campbell
Protein Kinase C Regulates Expression and Function of Inhibitory Killer Cell Ig-Like Receptors in NK Cells
J. Immunol., October 15, 2007; 179(8): 5281 - 5290.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K. Yoshida, T. Yamaguchi, H. Shinagawa, N. Taira, K. I. Nakayama, and Y. Miki
Protein Kinase C {delta} Activates Topoisomerase II{alpha} To Induce Apoptotic Cell Death in Response to DNA Damage.
Mol. Cell. Biol., May 1, 2006; 26(9): 3414 - 3431.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Yoshida, H. Liu, and Y. Miki
Protein Kinase C {delta} Regulates Ser46 Phosphorylation of p53 Tumor Suppressor in the Apoptotic Response to DNA Damage
J. Biol. Chem., March 3, 2006; 281(9): 5734 - 5740.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Chen, M. Levis, P. Brown, K.-T. Kim, J. Allebach, and D. Small
FLT3/ITD Mutation Signaling Includes Suppression of SHP-1
J. Biol. Chem., February 18, 2005; 280(7): 5361 - 5369.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. A. DeVries, R. L. Kalkofen, A. A. Matassa, and M. E. Reyland
Protein Kinase C{delta} Regulates Apoptosis via Activation of STAT1
J. Biol. Chem., October 29, 2004; 279(44): 45603 - 45612.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. L. Jones, J. D. Craik, J. M. Gibbins, and A. W. Poole
Regulation of SHP-1 Tyrosine Phosphatase in Human Platelets by Serine Phosphorylation at Its C Terminus
J. Biol. Chem., September 24, 2004; 279(39): 40475 - 40483.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Duchesne, S. Charland, C. Asselin, C. Nahmias, and N. Rivard
Negative Regulation of beta -Catenin Signaling by Tyrosine Phosphatase SHP-1 in Intestinal Epithelial Cells
J. Biol. Chem., April 11, 2003; 278(16): 14274 - 14283.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Liu, J. Chen, Q. Dai, and R. M. Lee
Phospholipid Scramblase 3 Is the Mitochondrial Target of Protein Kinase C {delta}-induced Apoptosis
Cancer Res., March 15, 2003; 63(6): 1153 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Yoshida, Y. Miki, and D. Kufe
Activation of SAPK/JNK Signaling by Protein Kinase Cdelta in Response to DNA Damage
J. Biol. Chem., December 6, 2002; 277(50): 48372 - 48378.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics